MD Healthcare Inc.
생명공학 연구
Converging microbiome and nanovesicle technology for chronic inflammatory disease therapeutics and diagnostics.
소개
MD Healthcare Inc. is a microbiome-based precision medicine venture established in Seoul, South Korea in 2014. We have conducted metagenomic analysis of tens of thousands of clinical samples and found that microbial extracellular vesicles (EVs) are powerful biomarkers for disease diagnosis and potent therapeutic agents. Using our proprietary microbial EV postbiotic technology, we are developing a variety of drug pipelines, diagnostic kits, and personalized healthcare services. By harnessing our microbial EV technology, we are developing pre-clinical core drug pipelines for immuno-oncology, respiratory, GI, skin, and CNS disease treatment in addition to AI-driven non-invasive diagnostic tools for various chronic diseases.
- 웹사이트
-
http://www.mdhc.kr/en
MD Healthcare Inc. 외부 링크
- 업계
- 생명공학 연구
- 회사 규모
- 직원 11-50명
- 본사
- Seoul
- 유형
- 비상장기업
- 설립
- 2014
- 전문 분야
- Microbiome, Nanovesicles, Extracellular Vesicles, Chronic Disease, Inflammatory Disease, Cancer, Therapeutics, Diagnostics, Biotechnology, Microbial EVs, Respiratory Disease, Immuno-oncology, CNS Disease, Postbiotics, Metagenomics 및 Nano Cosmos
위치
-
기본
1301 Woori Technology Bldg., 9 World Cup buk-ro 56-gil, Mapo
KR Seoul